QubeHealth-Pay (“QubePay”), the company that is building the financial infrastructure layer for healthcare in India, today announced its expansion into the Middle East and North Africa (MENA) region with the launch of Qube FinTech & AI MENA Limited (“Qube MENA”), a newly licensed entity operating out of the Dubai International Financial Centre (DIFC), home to global fintech firms such as Stripe and Wise and financial institutions including BlackRock, Goldman Sachs and Nomura.. The DIFC entity becomes Qube’s regional headquarters for the Gulf Cooperation Council (GCC) and North Africa — the company’s first market outside India.

Qube MENA is structured differently from QubePay, the consumer payments and cashback platform Qube operates in India. In the DIFC, Qube is built to serve insurers, employers, hospital networks, pharmaceutical companies and other enterprise participants across the region, licensing its purpose-built technology to solve financial problems within the healthcare sector. Its capabilities include digital healthcare expense processing, claims facilitation and documentation, rule-based bill adjudication support, reconciliation infrastructure, and aggregated, consent-driven healthcare data and insights for insurers, employers and healthcare brands.

The expansion responds to a widening healthcare affordability gap across the region. Healthcare costs are rising an estimated 8–12% annually across MENA — outpacing wage growth and, in many markets, government healthcare spending. Even in relatively well-insured markets such as the UAE, large categories of care — including IVF and fertility treatment, dental implants, cosmetic and elective procedures, and wellness programmes — remain entirely self-funded. Out-of-pocket healthcare spending is markedly higher elsewhere in the region, particularly across parts of North and East Africa, where insurance penetration remains limited, and insurance companies are keen to solve various problems related to healthcare payments – a core mission of QubeHealth-Pay.

Qube’s initial regional focus spans four markets — the UAE, Egypt, Kenya and Nigeria — with Dubai serving as the operating and regulatory base. Each market will be entered through an approach suited to its own regulatory and insurance landscape, combining partnerships with local insurers, healthcare providers and financial institutions with selective technology-licensing arrangements. The company plans a phased rollout: beginning with regulatory engagement and partnership-building, followed by pilot deployments, and broader enterprise onboarding thereafter.

Qube’s India platform — live across more than 300 corporates and reaching over 300,000 employee families — is the operating and product base being localised for MENA’s healthcare systems, insurance structures and regulatory frameworks.

Speaking on the announcement, Chris George, Co-Founder & Group CEO, said, “The out-of-pocket healthcare problem we’ve spent years solving in India isn’t unique to India — it shows up across the Middle East and Africa too, just in different forms. In the UAE, it’s the elective and non-insurable care that falls entirely outside insurance. In markets like Egypt, Kenya and Nigeria, it’s the everyday cost of pharmacy, diagnostics and outpatient care. Setting up in the DIFC gives us a credible, regulated base to build the technology and data infrastructure insurers, employers and healthcare providers across the region need to manage this — the same problem, adapted to how healthcare is actually paid for and insured here.”

Out-of-pocket (OOP) healthcare spending varies significantly across Qube’s target markets. In Dubai, the Dubai Health Authority’s Health Accounts System (HASD) 2022 report put household OOP spending at approximately 10% of current health expenditure — low by regional standards because of mandatory health insurance, though this figure excludes non-insurable elective categories such as IVF, cosmetic and dental procedures, which are paid for entirely out of pocket and not captured in official OOP statistics. Out-of-pocket spending is markedly higher elsewhere in the region, particularly across parts of North and East Africa, where insurance penetration remains limited. These figures are drawn from company research current as of 2026 and should be independently verified before reuse, as national health-expenditure data is revised periodically.